Prevalence of Thalassemia Trait & Iron Deficiency Anemia during Infancy in 2011-2013 in a Thalassemia Prevalent Region: North Cyprus
-
Burçin ŞANLIDAĞ
,
Buse ÇAĞIN
,
Övgü ÖZENLİ
,
Özlem ŞAHALOĞLU
,
Ceyhun DALKAN
,
Nilüfer GALİP
,
Arzu BABAYİĞİT HOCAOĞLU
,
Nerin BAHÇECİLER
Abstract
Background: Iron Deficiency Anemia (IDA) is an important health problem all around the world especially in developing countries. In the Mediterranean countries another prevelant reason of anemia is Thalassemia. Certain strategies had been established as a government policy to reduce prevalence in North Cyprus, such as pre-marital screening of Thalassemia. The prevalence of thalassemia trait has not been evaluated since then. The aim of this study was to detect the prevalence of IDA, thalassemia trait in infants under regular follow-up and to evaluate the compliance to prophylactic iron supplementation (PIS) and its effect on IDA.
Methods: Healthy children admitted to Department of Pediatrics, Near East University Hospital, in 2011–2013 were included. Data of anthropometric measurements, parental thalassemia trait status, duration of PIS usage, complete blood count, ferritin levels and hemoglobin electrophoresis were collected from hospital database program. Anemic children were grouped as IDA, thalassemia trait, both IDA and thalassemia trait and others.
Results: Eıghty-nine infants with a mean age 13.52±2.09 mo were included. Compliance with PIS recommendation was 85.3% and, the mean duration of iron usage was 6.44±3.18 mo. IDA and thalassemia trait were found to be 11.2% and 4.5% respectively, while 3.4% of the infants had both IDA and thalassemia trait.
Conclusion: Prevalence of thalassemia trait was 7.9% demonstrating approximately a 50% decline within 5 decades. This result confirms the success of premarital screening policy in North Cyprus. In addition, prevalence of IDA was relatively low being 14.6% supporting the beneficial effect of PIS on prevention of IDA.
Benoist B, McLean E, Cogswell M (2008). Worldwide prevalence of anaemia 1993-2005. WHO Global Database on Anaemia. World Health Organization, Switzerland. http://apps.who.int/iris/bitstream/10665/43894/1/9789241596657_eng.pdf.
Dos Reis MC, Nakano AS, Silva IA, Gomes FA, Pereira MJ (2010). Prevalence of Anemia in Children Three to 12 Months Old in a Health Service in Ribeirão Preto, SP, Brazil. Rev Lat Am Enfermagem,18:792-799.
Moy RJ, Early AR (1999). Iron deficiency in childhood. J R Soc Med, 92: 234-236.
Olivares M, Walter T, Hertampf E, Pizarro F (1999). Anaemia and iron deficiency disease in Children. Br Med Bull, 55: 534-543.
Bozkurt G (2007). Results from the North Cyprus thalassemia prevention program. Hemoglobin, 31: 257- 264.
Cao A, Kan YW (2013). The Prevention of Thalassemia. Cold Spring Harb Perspect Med, 1; 3(2):a011775.
Yip R, Schwartz S, Deinard AS (1983). Screening for Iron Deficiency with the Erythrocyte Protoporphyrin Test. Pediatrics, 72: 214 -219.
Modell B, Bulzhenov V (1988). Distribution and control of some genetic disorders. World Health Stat Q, 41: 209-218.
Choudhry VP, Kotwal J, Saxena R (1998). Thalassemia screening and control program. Pediatrics Today, 1: 283-286.
Angastiniotis MA, Hadjiminas MG (1981). Prevention of thalassemia in Cyprus. Lancet, 1: 369-371.
Ashiotis T, Zachariadis Z, Sofroniadou K, Loukopoulos D, Stamatoyannopoulos G (1973). Thalassemia in Cyprus. Br Med J, 2: 38–42.
Tschudy M, Arcara K (2012). Hematology. In: The Harriet Lane Handbook: A manual for pediatric house officers. Eds, Tschudy and Arcara 19th ed, Elsevier Mosby. Philedelphia, pp:322-353.
Kurt AS, Savaşer S (2010). Çocuklarda Demir Eksikliği Anemisinin Sıklığı, Nedenleri ve Korunma Yolları: Literatür Taraması. Deuhyo Ed. 3: 201-208.
Kyrri AR, Kalogerou E, Loizidou D, Ioannou C, Makariou C, Kythreotis L, Phylactides M., Kountouris P, Angastiniotis M, Modell B, Kleanthous M (2013). The changing epidemiology of β-thalassemia in the Greek-Cypriot population. Hemoglobin, 37:435-443.
Haldane JBS (1949). The rate of human genetics. Proc VII Int Cong Fenet Hereditas. 35:267 – 273.
Angastiniotis MA, Kyriakidou S, Hadjiminas M (1986). How thalassemia was controlled in Cyprus. World Health Forum, 7:291-297.
Johnson D (2010). First AAP recommendations on iron supplementation include directive on universal screening. American Academy of Pediatrics, Illinois, United States of America. http://www.aappublications.org/content/early/2010/10/05/aapnews.20101005-1
Baker RD, Greer FR, Committee on Nutrition American Academy of Pediatrics (2010). Diagnosis and Prevention of Iron Deficiency and Iron-Deficiency Anemia in Infants and Young Children (0−3 Years of Age). Pediatrics. 126:1040-1050.
Yalcin S, Pekcan G, Tezel B, Koksal E, Ozbas S, Yurdakok K, Tunc B, Altunsu T, Köse R, Buzgan T, Akdag R (2009). 12-23 aylık çocuklarda demir kullanım araştırmsı raporu. 1st edition. Ana Çocuk Sağlığı Aile Planlaması Genel Müdürlüğü Matbaası. Turkey. pp:39-84.
Booth IW, Aukett MA, Logan S (1997). Iron deficiency anaemia in infancy and early childhood. Arch Dis Child, 76:549-554.
Earley A, Valman HB, Altman DG, Pippard MJ (1990). Microcytosis, iron deficiency, and thalassemia in preschool children. Arch Dis Child,65: 610-614.
Pita GM, Jiménez S, Basabe B, García RG, Macías C, Selva L, Hernández C, Cruz M,Herrera R,O’Farrill R, Calderius I, Paulí K, Leyva M, Arocha C, Herrera D (2014). Anemia in Children under Five Years Old in Eastern Cuba, 2005–2011. MEDICC Rev, 16: 16-23.
Zetterström R (2004). Iron deficiency and iron deficiency anaemia during infancy and childhood. Acta Paediatr, 93: 436-439.
Lutter CK (2008). Iron Deficiency in Young Children in Low-Income Countries and New Approaches for Its Prevention. J Nutr, 138: 2523-2528.
| Files | ||
| Issue | Vol 45 No 8 (2016) | |
| Section | Original Article(s) | |
| Keywords | ||
| Anemia Thalassemia trait Iron deficiency Infant | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
